GlassScriptPhysician profile
Shashi Puttaswamy
NPI 1316055304
$523.75
in general payments reported to CMS, 2019-2025
20 companies · $14.14 in 2025
The $14.14 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $510 · 2025: $14.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $120.19 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $62.46 | 2019 | |
| Glaxosmithkline, LLC. | $47.62 | 2019 | |
| Abbvie INC. | $30.88 | 2019 | |
| Duchesnay USA Incorporated | $29.02 | 2019 | |
| Lilly USA, LLC | $24.62 | 2019 | |
| Amgen INC. | $22.51 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $22.26 | 2019 | |
| Shire North American Group INC | $17.35 | 2019 | |
| Amarin Pharma, INC. | $15.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.15 | 2019 | |
| Mission Pharmacal Company | $14.54 | 2019 | |
| Tactile Systems Technology INC | $14.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.17 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.79 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $13.05 | 2019 | |
| Astellas Pharma US INC | $12.74 | 2019 | |
| Pfizer INC. | $11.21 | 2019 | |
| Mannkind Corporation | $11.01 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashi Puttaswamy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.